Ciba Vision's Margins Declined In 2000

Novartis has again indicated that it may sell off its eye care division to help finance the acquisition of an American drugs company, although there are no immediate plans. Daniel Vasella, chairman of the Swiss-based group, has made it clear in recent statements that it considers its pharmaceutical business as ...

To continue reading this article subscribe now

barrier_image_OIC

Become a member today for full access from just €6,70 a week!

Buying a membership today will give you:

  • Our executive edition of Eyewear Intelligence (Regular PDF format or E-Format) - the must-read for all decision-makers in the industry
  • Weekly E-mail Briefing from the Chief Editor with the lastest analysis and most important industry developments
  • Case studies and best practices on business challenges
  • Guest chronicles, interviews, insights from industry experts and leaders that are shaping the future of the industry
  • Unlimited access to ewintelligence.com - all insight, analysis and statistics available online
  • Access to over 11,500 articles and analyses in the archive
  • Personal library to save articles and track your key content
  • Powerful search and intuitive navigation
  • Breaking news

Already an Eyewear Intelligence subscriber? Sign in here.